TABLE 2 from the Inherited KRAS-variant As a Biomarker of Cetuximab Response in NSCLC
Joanne B. Weidhaas,Chen Hu,Ritsuko Komaki,Gregory A. Masters,George R. Blumenschein,Joe Y. Chang,Bo Lu,Adam P. Dicker,Jeffrey A. Bogart,Yolanda I. Garces,Samir Narayan,Clifford G. Robinson,Vivek S. Kavadi,Joel S. Greenberger,Christopher D. Koprowski,James Welsh,Elizabeth M. Gore,Robert M. MacRae,Rebecca Paulus,Jeffrey D. Bradley openalex（2023）
关键词
Biomarker Analysis,KRAS Mutations,Cetuximab
AI 理解论文
溯源树
样例
